| 50090-4364 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4364 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4364 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4364 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5029 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5029 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5033 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5033 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5033 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5034 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5034 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5034 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5034 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | .Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | .Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health 107, LLC | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health 107, LLC | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | .Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | .Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |